A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(11 sites)

United States

Medstar Washington Hospital Center, Washington D.C., District of Columbia

University of Kansas Medical Center, Kansas City, Kansas

University of Maryland Medical Center, Baltimore, Maryland

University of Maryland - Baltimore Washington Medical Center, Glen Burnie, Maryland

Ocean Springs Hospital, Ocean Springs, Mississippi

Washington University School of Medicine, St Louis, Missouri

Cooper University Hospital, Camden, New Jersey

The Mount Sinai Hospital, New York, New York

Cleveland Clinic, Cleveland, Ohio

Houston Methodist Hospital, Houston, Texas

Intermountain Medical Center, Murray, Utah